Medical Expertise

Internal Medicine
Cardiovascular Disease
Echocardiography
Interventional Cardiology
Heart Failure & Transplant

Hospital Affiliation

University Hospital, Newark

INSURANCE PARTICIPATION

Insurance Participation: with Provider Number (where applicable)
The information below is subject to change and should not be relied upon until after it is verified with the insurance company. In addition, psychiatric providers should be contacted directly for information on their participation with managed care and insurance companies.

Aetna, Inc.

AmeriGroup

AmeriHealth of NJ

America's Choice Provider Network (ACPN)

Amerivantage Dual Coordination

CHN Solutions

Clover Health Plans

Devon Health Services/ULLICO

Horizon BCBS Managed Care

Horizon NJ Health

Horizon NJ Total Care(HNJH)

Horizon PPO Network

Magnacare

Medicaid

Medicare

MultiPlan

Prime Health Services, Inc.

Qual Care HMO

Qual Care PPO

Three Rivers Provider Network

UHC Comm/Oxford

United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)

VA Choice (Health Net Federal Services)

WellCare Health Plans

Overview

Marc Klapholz, MD, FACC, FSCAI is Professor & Chair, Department of Medicine, Chief of Service and Director, Division of Cardiology at Rutgers - New Jersey Medical School in New Jersey. He also serves as the Director of the Heart Failure Prevention and Treatment Program.

Dr. Klapholz received his medical degree from the Albert Einstein College of Medicine, Bronx, New York. He completed his residency in internal medicine, an NIH sponsored Heart Failure Research Fellowship, General Cardiology and Interventional Cardiology Fellowship at the Albert Einstein College of Medicine and Bronx Municipal Hospital Center. He is board-certified in Internal Medicine, Cardiovascular Disease, Echocardiography and Interventional Cardiology and Heart Failure & Transplant.

Dr. Klapholz has been a principal investigator on over 100 clinical trials in heart failure and other cardiovascular diseases. He serves on AHA Grant Review Committees, the Heart Failure Society of America Guidelines Committee and on the Editorial Board of several journals. He has been the chairman and member of numerous Steering, Endpoint and Data Safety Monitoring Board Committees for national and international trials in heart failure.

His major research interests include the evaluation of novel therapeutic agents and devices for the treatment of heart failure. He has authored and co-authored numerous articles, book chapters, monographs, and reviews in cardiovascular disease.

Education

M.D., 1986, Albert Einstein College of Medicine
B.A., 1981, Yeshiva University College

Licensure & Certification

Medical Licensure
New Jersey

Relevant Publications

Kishi A, Togo F, Cook DB, Klapholz M, Yamamoto Y, Rapoport DM, Natelson BH. The effects of exercise on dynamic sleep morphology in health controls and patients with chronic fatigue syndrome. Physiol Rep. 2013 Nov;1(6):e00152. doi: 10.1002/ph2.152. Epub 2013 Nov 13.

Nakamura T, Schwander S, Donnelly R, Cook DB, Ortega F, Yamamoto Y, Cherniack NS, Klapholz M, Rapoport D, Natelson BH. Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndrome. Clin Vaccine Immunol. 2013 Nov;20(11):1736-42. doi: 10.1128/CVI.00527-13. Epub 2013 Sep 11.

Alhaj E, Alhaj EK, Rahman I, Niazi TO, Berkowitz R, Klapholz M. Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail. 2013 Jul-Aug;19(4):E40-5. doi:10.1111/chf.12030. Epub 2013 Apr 25. Review. PMID:23615021.

Alhaj EK, Alhaj NK, Klapholz M. Fibromuscular dysplasia of the renal artery: an under diagnosed cause of severe hypertension. Int J Cardiol. 2013 Sept 10:167(6):e159-60. doi:10.1016/ j.ijcard.2013.04.189. Epub 2013 May 17. PMID:23684605

Alhaj E, Ahmad US, Niazi OT, Zakhary D, Akhtar M, Zabolotsky A, Oriscello R, Voudouris A, Kaluski E, Klapholz M. Atypical stress-induced cardiomyopathy: a case series. Acta Cardiology. 2013 April;68(2):222-5. PMID:23705571

Rudzinski W, Waller AH, Rusovici A, Dehnee A, Nasur A, Benz M, Sanchez S, Klapholz M, Kaluski E. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Cathether Cardiovasc Interv. 2013 Feb;81(3):540-4. Doi: 10.1002/ccd.24652. Epub 2012 Oct 15. PMID 22961876

Mathur AP, Waller AH, Dhruvakumar S, Mazza V, Gerula C, Maher J, Klapholz M, Kaluski E. Minerva Cardioangiol. 2012 Dec;60(6):611-28. Review. PMID:23147438

Rusovici A, Ibrahim S, Sood S, Maher J, Gerula C, Kaluski E, Klapholz M. Extensive myocardial iron deposition in a patient with hepatitis C. Tex Heart Inst J. 2012;39(2):281-283. PMID:2274075

Rudzinski W, Waller A, Rusovici A, Dehnee A, Nasur A, Benz M, Sanchez S, Klapholz M, Kaluski E. Comparison of efficacy and safety of intracoronary sodium nitroprussid and intravenous adenosine for assessing fractional flow reserve. Catheter Cardiovasc Interv. 2012 Sept; 7.doi:1.1002/ccd.24652 (Epub ahead of print). PMID:22961876

Rudzinski W, Waller AH, Prasad A, Sood S, Gerula C, Samanta A, Koneru B, Klapholz M. New index for assessing chronotropic response in patients with end stage liver disease who are undergoing dobutamine stress echocardiography. Liver Transpl. 2012 Mar;18(3):355-60. PMID:22140006